National Cancer Waiting Times Monitoring Data Set: Scenarios

National Cancer Waiting Times Monitoring Data Set

Concept of Operation and Patient Pathway Scenarios:

The National Cancer Waiting Times Monitoring Data Set is a generic data set designed to support the monitoring of waiting times for a variety of different pathways of cancer care. For the purpose of this data collection cancer is defined using the International Classification of Diseases (ICD) codes. The full list of International Classification of Diseases (ICD) diagnosis codes is available on the NHS Digital website at: Cancer Waiting Times.

Collection and submission of the National Cancer Waiting Times Monitoring Data Set is to be managed according to the maximum waiting time and information requirements of the pathway of care for each individual PATIENT. These requirements for providers of cancer SERVICES to return data to the Cancer Waiting Times Database are defined using different scenarios.

The columns in the table below show which data items are required for a range of health care scenarios:

Data Set Notation:

Note: Inter-Provider Transfers:

Data ItemScenario 1aScenario 1bScenario 1cScenario 1dScenario 1eScenario 1fScenario 1gScenario 2aScenario 2bScenario 2cScenario 3Scenario 4Scenario 5Scenario 6Scenario 7
NHS NUMBERMMMMMMMMMMMMMMM
NHS NUMBER STATUS INDICATOR CODEMMMMMMMMMMMMMMM
PATIENT PATHWAY IDENTIFIERMMMMMMMM*M*M*M*M*M*M*M*
ORGANISATION IDENTIFIER (PATIENT PATHWAY IDENTIFIER ISSUER)MMMMMMMM*M*M*M*M*M*M*M*
SOURCE OF REFERRAL FOR OUT-PATIENTSMMMMMN/AMN/AN/AN/AN/AMN/AON/A
PRIORITY TYPE CODEMMMMMN/AMN/AN/AN/AN/AMN/AON/A
DECISION TO REFER DATE (CANCER OR BREAST SYMPTOMS)M*M*M*M*M*N/AM*N/AN/AN/AN/AN/AN/AON/A
CANCER REFERRAL TO TREATMENT PERIOD START DATEMMMMMN/AMMN/AN/AN/AON/AON/A
TWO WEEK WAIT CANCER OR SYMPTOMATIC BREAST REFERRAL TYPEMMMMMN/AMN/AN/AN/AN/AN/AN/AON/A
CONSULTANT UPGRADE DATEN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AMN/AON/A
ORGANISATION SITE IDENTIFIER (OF PROVIDER CONSULTANT UPGRADE)N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AMN/AON/A
DATE FIRST SEENMMMMMN/AMN/AN/AN/AN/AMN/AON/A
ORGANISATION SITE IDENTIFIER (OF PROVIDER FIRST SEEN)MMMMMN/AMN/AN/AN/AN/AMN/AN/AN/A
WAITING TIME ADJUSTMENT (FIRST SEEN)M*M*M*M*M*N/AM*N/AN/AN/AN/AO*N/AN/AN/A
WAITING TIME ADJUSTMENT REASON (FIRST SEEN)M*M*M*M*M*N/AM*N/AN/AN/AN/AO*N/AN/AN/A
CANCER CARE SPELL DELAY REASON (FIRST SEEN)M*M*M*M*M*N/AM*N/AN/AN/AN/AN/AN/AN/AN/A
CANCER CARE SPELL DELAY REASON COMMENT (FIRST SEEN)O*O*O*O*O*N/AO*N/AN/AN/AN/AN/AN/AN/AN/A
MULTIDISCIPLINARY TEAM CANCER CARE PLAN DISCUSSED INDICATORM*M*M*M*M*M*M*M*M*M*M*M*M*M*M*
MULTIDISCIPLINARY TEAM DISCUSSION DATE (CANCER)M*M*M*M*M*M*M*M*M*M*M*M*M*M*M*
CANCER OR SYMPTOMATIC BREAST REFERRAL PATIENT STATUSMMMMMMMMMMMMMMM
PRIMARY DIAGNOSIS (ICD)N/AM*M*M*N/AN/AN/AMMMMMMMM
TUMOUR LATERALITYN/AM*M*M*N/AN/AN/AMMMMMMMM
CANCER TREATMENT PERIOD START DATEN/AN/AMMN/AN/AN/AMMMMMMMM
ORGANISATION SITE IDENTIFIER (OF PROVIDER CANCER DECISION TO TREAT)N/AN/AMMN/AN/AN/AMMMMMMMM
SERVICE REQUESTED DATE (INTER-PROVIDER TRANSFER) #N/AN/AN/AN/AMN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
REFERRAL REQUEST RECEIVED DATE (INTER-PROVIDER TRANSFER) #N/AN/AN/AN/AN/AMN/AN/AMMN/AN/AN/AN/AN/A
ORGANISATION IDENTIFIER (REFERRING) #N/AN/AN/AN/AMMN/AN/AMMN/AN/AN/AN/AN/A
ORGANISATION IDENTIFIER (RECEIVING) #N/AN/AN/AN/AMMN/AN/AMMN/AN/AN/AN/AN/A
CANCER TRANSFER REFERRING REASON (INTER-PROVIDER TRANSFER) #N/AN/AN/AN/AMN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
CANCER TRANSFER RECEIVING REASON (INTER-PROVIDER TRANSFER) #N/AN/AN/AN/AN/AMN/AN/AMMN/AN/AN/AN/AN/A
SERVICE REQUESTED DATE (INTER-PROVIDER TRANSFER) ##N/AN/AN/AN/AN/AMN/AN/AN/AN/AN/AN/AN/AN/AN/A
REFERRAL REQUEST RECEIVED DATE (INTER-PROVIDER TRANSFER) ##N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
ORGANISATION IDENTIFIER (REFERRING) ##N/AN/AN/AN/AN/AMN/AN/AN/AN/AN/AN/AN/AN/AN/A
ORGANISATION IDENTIFIER (RECEIVING) ##N/AN/AN/AN/AN/AMN/AN/AN/AN/AN/AN/AN/AN/AN/A
CANCER TRANSFER REFERRING REASON (INTER-PROVIDER TRANSFER) ##N/AN/AN/AN/AN/AMN/AN/AN/AN/AN/AN/AN/AN/AN/A
CANCER TRANSFER RECEIVING REASON (INTER-PROVIDER TRANSFER) ##N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
CANCER FASTER DIAGNOSIS PATHWAY END REASONN/AMN/AMN/AN/AMMMN/AM*N/AN/AN/AN/A
PRIMARY CANCER SITE (CANCER FASTER DIAGNOSIS PATHWAY)N/AMN/AMN/AN/AN/AMMN/AN/AN/AN/AN/AN/A
CANCER FASTER DIAGNOSIS PATHWAY END DATEN/AMN/AMN/AN/AMMMN/AM*N/AN/AN/AN/A
CANCER CARE SPELL DELAY REASON (OUTCOME COMMUNICATION CANCER FASTER DIAGNOSIS PATHWAY)N/AM*N/AM*N/AN/AN/AM*M*N/AN/AN/AN/AN/AN/A
CANCER CARE SPELL DELAY REASON COMMENT (OUTCOME COMMUNICATION CANCER FASTER DIAGNOSIS PATHWAY)N/AO*N/AO*N/AN/AN/AO*O*N/AN/AN/AN/AN/AN/A
CANCER FASTER DIAGNOSIS PATHWAY EXCLUSION REASONN/AN/AN/AN/AN/AN/AMN/AN/AN/AM*N/AN/AN/AN/A
CARE PROFESSIONAL TYPE CODE (OUTCOME COMMUNICATION CANCER FASTER DIAGNOSIS PATHWAY)N/AO*N/AO*N/AN/AN/AO*O*N/AN/AN/AN/AN/AN/A
METHOD OF COMMUNICATION (END OF CANCER FASTER DIAGNOSIS PATHWAY)N/AO*N/AO*N/AN/AN/AO*O*N/AN/AN/AN/AN/AN/A
ORGANISATION SITE IDENTIFIER (OF CANCER FASTER DIAGNOSIS PATHWAY END DATE)N/AMN/AMN/AN/AMMMN/AM*N/AN/AN/AN/A
TREATMENT START DATE (CANCER)N/AN/AN/AN/AN/AN/AN/AMMMMMMMM
ORGANISATION SITE IDENTIFIER (OF PROVIDER CANCER TREATMENT START DATE)N/AN/AN/AN/AN/AN/AN/AMMMMMMMM
CANCER TREATMENT EVENT TYPEN/AN/AN/AN/AN/AN/AN/AMMMMMMMM
CANCER TREATMENT MODALITYN/AN/AN/AN/AN/AN/AN/AMMMMMMMM
CLINICAL TRIAL INDICATORN/AN/AN/AN/AN/AN/AN/AMMMMMMMM
CANCER CARE SETTING (TREATMENT)N/AN/AN/AN/AN/AN/AN/AMMMMMMMM
RADIOTHERAPY PRIORITYN/AN/AN/AN/AN/AN/AN/AM*M*M*M*M*M*M*M*
CANCER CARE SPELL DELAY REASON (DECISION TO TREATMENT)N/AN/AN/AN/AN/AN/AN/AM*M*M*M*M*M*M*M*
CANCER CARE SPELL DELAY REASON COMMENT (DECISION TO TREATMENT)N/AN/AN/AN/AN/AN/AN/AO*O*O*O*O*O*O*O*
WAITING TIME ADJUSTMENT (TREATMENT)N/AN/AN/AN/AN/AN/AN/AM*M*M*M*M*M*M*M*
WAITING TIME ADJUSTMENT REASON (TREATMENT)N/AN/AN/AN/AN/AN/AN/AM*M*M*M*M*M*M*M*
CANCER CARE SPELL DELAY REASON (REFERRAL TO TREATMENT)N/AN/AN/AN/AN/AN/AN/AM*M*M*N/AM*N/AO*N/A
CANCER CARE SPELL DELAY REASON COMMENT (REFERRAL TO TREATMENT)N/AN/AN/AN/AN/AN/AN/AO*O*O*N/AO*

O*

O*N/A
CANCER CARE SPELL DELAY REASON (CONSULTANT UPGRADE)N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AM*N/AO*N/A
CANCER CARE SPELL DELAY REASON COMMENT (CONSULTANT UPGRADE)N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AO*N/AO*N/A

Full details of the validation rules and processes are available on the NHS Digital website at: Cancer Waiting Times.